4 Deals Stopped by COVID-19 and 4 That Kept Going Despite the Virus4 Deals Stopped by COVID-19 and 4 That Kept Going Despite the Virus

Here are four deals that were successful and four deals that didn’t turn out so well during the pandemic.

Omar Ford

July 30, 2020

8 Slides
IMG_Jul302020at25511PM.jpg

Already have an account?

momius -stock.adobe.com

Sometimes deals close. Sometimes they go south and get canceled. MD+DI is looking at how the novel coronavirus has impacted deals during the COVID-19 pandemic. So, here are five deals that were successful and five deals that didn’t turn out so well.

(Editor’s Note: When we say deals, we’re including more than just M&A. We’re also including financings too!)

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like